GLP-1/GIP/glucagon receptor Triagonist therapy(Rani Therapeutics)

N/A

Report date: 2026/04/16 20:00:17

Base Information

Drug NameGLP-1/GIP/glucagon receptor Triagonist therapy(Rani Therapeutics)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionGlucagon receptor agonistsGlucagon-like peptide 1 receptor agonistsGlucose-Dependent Insulinotropic Polypeptide Receptor agonists
TargetsGlucagon receptorGlucagon-like peptide 1 receptorGlucose-Dependent Insulinotropic Polypeptide Receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRani Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesRani Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A